Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure. In this multinational, open-label, randomised, parallel-group trial (STRONG-HF), patients aged 18–85 years admitted to hospital with acute hea...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 400; no. 10367; pp. 1938 - 1952
Main Authors:	Mebazaa, Alexandre, Davison, Beth, Chioncel, Ovidiu, Cohen-Solal, Alain, Diaz, Rafael, Filippatos, Gerasimos, Metra, Marco, Ponikowski, Piotr, Sliwa, Karen, Voors, Adriaan A, Edwards, Christopher, Novosadova, Maria, Takagi, Koji, Damasceno, Albertino, Saidu, Hadiza, Gayat, Etienne, Pang, Peter S, Celutkiene, Jelena, Cotter, Gad
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 03.12.2022 Elsevier Limited Elsevier
Subjects:	Adverse events Angiotensin Blood pressure Brain natriuretic peptide Cardiology Cardiology and cardiovascular system Congestive heart failure Death Effectiveness Enzymes Female Health services Heart Failure Hospitals Human health and pathology Humans Laboratories Life Sciences Male Middle Aged Mineralocorticoid Receptor Antagonists - therapeutic use Minority & ethnic groups Missing data Mortality Patients Peptides Potassium Quality of Life Renin Risk Risk reduction Safety Stroke Volume Titration Treatment Outcome Ventricle Ventricular Function, Left
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!